莫雅德律师是瑞格律师事务所亚洲区管理合伙人，生命科学及私募股权业务团队的一名合伙人，同时也是本所上海办公室的创始人。自2004年起，莫律师开始在中国为客户就跨境并购、私募股权、风险投资融资、合资合作经营和复杂商业安排等业务提供法律服务。莫律师主要协助跨国制药企业、医疗器械公司、生物技术和科技行业的企业家，以及在中国寻求投资机会的生命科学和医疗保健投资基金。此外，莫律师还致力于为领先的美国医院和其他医疗保健服务机构在中国开展交易提供法律咨询服务。在此之前，莫律师曾在一家国际性律师事务所的华盛顿特区总部为客户提供生命科学并购和私募股权交易的法律咨询服务。
China represents a strategic priority market for many companies and investors in today’s evolving life sciences industry. Featuring the unique insights of our full-service legal team in China, this site contains valuable resources to assist clients in navigating the legal complexities of market conditions and industry trends within the region. Learn more.
Ropes & Gray advised dermatology company Profex Inc. in the establishment of an equity joint venture and exclusive distribution relationship with Paris-based HRA-Pharma SAS. Under the terms of the agreement, Profex will be the exclusive distributor of, and ...
On Wednesday, April 25, Ropes & Gray hosted a China Life Sciences Summit that featured a presentation by life sciences partners Arthur Mok and Katherine Wang, intellectual property partner Geoffrey Lin and government enforcement partner David Zhang on regional market ...
